Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-9mbdj3Phase 2Completed
Phase 2, open-label, single-arm trial in stasis ulcer, sponsored by UNESP Botucatu Medical School. Primary endpoints: Safety assessment and Dose assessment. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-9mbdj3.